Xenetic Biosciences regains Nasdaq minimum bid price compliance

Xenetic Biosciences, Inc.

Received Nasdaq letter on May 30, 2023 confirming compliance with Listing Rule 5550(a)(2).
Compliance achieved after closing bid price >= $1.00 for 10 consecutive days (May 15-26, 2023).
Previous deficiency was notified on June 3, 2022; this matter is now closed.

item 8.01

Xenetic Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-003826

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.